Learn More
STEMCELL Technologies Bafilomycin A1
Inhibits autophagy and vacuolar H+-ATPase (V-ATPase)
Brand: STEMCELL Technologies 74242

Description
- Bafilomycin A1 is a macrolide antibiotic drug and autophagy inhibitor
- It prevents the acidification of autophagosomes via the inhibition of vacuolar H+-ATPase (V-ATPase; Klionsky et al.)
- Inhibits the proteolytic degradation associated with autophagy in human mesenchymal stem cells (Oliver et al.)
- At low concentrations, it inhibits autophagy and promotes apoptotic cell death in pediatric B cell acute lymphoblastic leukemia (B-ALL) cells (Yuan et al.)
Specifications
88899-55-2 | |
500 μg | |
≥95% |
NSC 381866 | |
C35H58O9 |
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.